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Epidermal Langerhans cells have been implicated in 
the process by which animals skin painted with highly 
reactive haptens, such as DNFB, develop contact hyper-
sensitivity. Compared to normal body wall skin, murine 
tail skin contains relatively few, unevenly distributed 
Langerhans cells; ultraviolet light exposure depletes the 
epidermis transiently of normal numbers of morpholog-
ically identifiable Langerhans cells. When mice are 
painted with DNFB on skin naturally or artificially de-
pleted of Langerhans cells, contact hypersensitivity is 
not induced. More importantly, these animals become 
specifically unresponsive to the chemical contact, and 
are unable to mount effective hypersensitivity reactions 
if presented subsequently with an immunogenic regi-
men. It is concluded that Langerhans cells provide the 
skin with an intricate dendritic network just beneath the 
keratinized layer, the function of which is to receive, 
process and present cutaneously applied antigens in an 
immunogenic form. When this barrier network is 
breached, the host responds to antigenic exposure by 
becoming profoundly and specifically unresponsive. Im-
plications of this hypothesis for epidermal virus infec-
tions and cutaneous malignancy are discussed. 
The precise manner by which the immunologic apparatus 
responds to antigen is dependent upon a number of factors of 
which route of antigen presentation is important. When small 
molecular weight, highly reactive substances that cause contact 
hypersensitivity are considered, route of init ial ant igen presen-
tation becomes crucial. The application of a potential contac-
tant directly to the skin induces a strong state of specific 
immunologic reactivity. When similar amounts of ant igen are 
ingested by mouth, or inoculated intravenously or intraperito-
neally, no comparable state of contact hypersensitivity results. 
Instead, exposure to simple chemicals (haptens) through non-
cutaneous routes frequently results in specific umesponsiveness 
such that treated individuals are specifically unable to respond 
to th e eliciting hapten [1-3]. To the skin biologist as well as the 
immunologist, it is of some importan ce to understand the 
reason(s) for this unique and special property of skin. 
Macher and Chase [ 4, 5] proved through a series of elegant, 
tedious experiments that sensitization following skin painting 
with hapten required an initial phase during which the hapten 
reacted directly with a constituent(s) of the skin . Although 
subsequent processing of this immunogenic signal took place in 
draining lymph nodes and beyond, the initial, molecular inter-
action between hapten and a component(s) of skin was essential. 
It is now known that genes within the major histocompatibility 
complex (H-2) of the mouse exert profound control over the 
sensitization process [6]. Vadas et al have shown that the 
development and successful adoptive transfer of delayed and/ 
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or contact hypersensitivity to DNFB [7], and fowl gamma 
globulin [8], is restricted by genes of H-2 regions K, I-A, D and 
I-A, respectively. Shelley and Juhlin [9] have demonstrated 
that haptenic molecules exposed to th e epidermis accumulate 
preferentially within Langerhans cells. 
Over the past 5 yr, the functional properties of Langerhans 
cells, especially in relation to irmnune responses, have been the 
object of considerable investigation [10]. At the present, these 
curious cells, located suprabasally tluoughout the epidermis 
but ontogenetically umelated to epithelium or nemal crest 
anlage, resemble macrophages-monocytes in several remarka-
ble ways [11]. In addition to their surface affinity for exogenous 
antigen, they can process and present ant igen as effectively in 
vitro to primed T lymphocytes as do conventional macrophages 
[12]. Langerhans cells have been seen beneath th e dermis and 
along relevant lymphatic drainage routes to regional lymph 
nodes in the context of delayed cutaneous hypersensitivity 
reactions [13]. It has been suggested, but not proven, t hat they 
derive ultimately from cells within the hematopoietic bone 
mruTow and may be replenished from that source dming adult 
life -[14]. It has recently been shown, from several different 
laboratories, that Langerhans cells are the only cells within the 
epidermis capable of expressing cell surface determinants en-
coded by I region determinants of H-2 [15]. Finally, Langerhans 
cells have been included as components of a hypothetical "re-
ticuloepithelial system" [16] devised to bind and process antigen 
applied to the skin and to preside over the dissemination of this 
immunogenic signal to central compartments of the immuno-
logic apparatus for differentiation into effector function. 
If Langerhans cells are in fact th e "rock" upon which devel-
opment of sensitization through skin rests, then skin deficient 
in these cells might be expected to be unable to sustain sensi-
tization to reactive molecules painted thereon. In the studies to 
be reported , we have taken advantage of2 observations to study 
this question: (1) skin that h as been treated with ultraviolet 
light becomes depleted t ransiently of Langer hans cells [17]; and 
(2) the tail skin of mice is naturally deficient in Langerhans 
cells when compru·ed to the density of these cells in normal 
body wall skin [17, 18]. 
MATERIALS AND METHODS 
Animals 
C57BL/ 6 mice obtained originally from the Jackson Laboratory, Bar 
Hru·bor, Maine, were bred and maintained in our colony. Two to 4-mo-
old mice were age matched for each experiment and received pelleted 
food and water ad lib. 
Antigens: 2,4-Dinitro-1-fluorobenzene (DNFB) and 4-ethoxynethy-
lene-2-phenyloxazol-5-one (Oxazalone) were obtained from Sigma 
Chemical Company, St. Louis, Mo. 
Sensitization and elicitation of contact sensitivity: Sites through 
which mice were sensitized were normal abdominal and dorsal body 
wall skin, UVL-treated abdominal wall skin and tail skin. Mice were 
sensi tized to DNFB by placing 251-ll of 0.5% DNFB in 4:1 acetone-olive 
oil on the shaved abdominal skin of recipients on day 0 and day 1. 
Sensitization with Oxazalone was done by placing 25 ILl of 10% Oxaza-
lone in the above vehicle on the abdomen on day 0 and day 1. For 
elicitation of contact sensitivity the eru· swelling assay employing paint-
ing with the appropriate antigen on day 5 was used. Eru· thickness was 
quantitated using a Mitatoya engineers micrometer as described by 
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P hanuphak, Moorhead, and Claman [3). The dorsal surface of the ears 
was then challenged with either 20 1-11 of 0.2% DNFB m 4:1 acetone-
olive oil or 20 ,ul of 1% oxazalone in the same vehicle. 24 and 48 hr after 
antigen challenge, the degree of ear thickness was again measured and 
results expressed in units of w-• inches. 
Positive controls consisted of normal mice who were sensitized on 
body wall skin in the manner described. Negative controls consisted of 
unsensitized mice that were ear challenged with the appropriate anti-
gen. 
Each panel-experimental, positive control , negative control-con-
sisted of at. least 5 age- and sex-matched animals. Only 24 hr readings 
are presented in the figures. 
Statistical analysis 
The statistical significance of differences in the means for each 
experimental group was calculated with Students t-test. Mean differ-
ences were considered significant when p < 0.05. 
Ultraviolet Light Treatment Source and Treatment 
Ultraviolet light (UVL) was administered with a bank of 3 FS-20 
"Sun Lamp" flu orescent tubes (Westinghouse, Pittsburgh, Pa.) . These 
tubes provide a continuous ultraviolet spectrum with a peak at 313 nm 
and high outpu t in th e sunburn spectrum (290-320 nm) . Tube to target 
distance measured 45 em. The minimal erythemal dose on untanned, 
human skin was 4.0 min, representing an output within the erythema 
range of 8 X 102 mJ/cm 2 sec. 
Langerhans cells were depleted with UV ligh t directed at a 2.5 em by 
2.5 em area of previously shaved abdomina l skin on each mouse. This 
site was exposed for 2 min on each of 4 successive days (days-3, -2, 
-1, 0) . This dose represented 0.5 minimal erythema l dose in untanned 
human skin, or 10 mJ/cm2 each day. 
EXPERIMENTS AND RESULTS 
Does Ultraviolet Light Treated-Skin Permit Sensitization to 
DNFB? 
We as well as others have shown that ultraviolet light (UVL), 
in the sunburn spectrum markedly affects the Langerhans cell 
population within the skin. Four treatments of mouse skin with 
2 min of UVL exposure at daily intervals results in the virtual 
disappearance of ATPase positive cells from the epidermis 
[17]. During the next 15 days, Langerhans cells gradually return 
to normal numbers and morphology. The abdominal skin of 
panels of mice was shaved and treated in this manner with 
either UVL or incandescent light. Following the 4th treatment, 
exposed skin of these mice was painted twice at 24 hr intervals 
with 25 p.l of 0.5% DNFB in carrier. Five days later each group 
of mice was challenged on the ear with 20 ,ul of 0.2% DNFB. As 
the results of this experiment, presented in the Table, reveal, 
UVL-treated skin was unable to promote sensitization when 
DNFB was applied to that skin in an imm\.mogenic manner. 
Incandescent light exposure had no comparable effect; these 
animals displayed strong contact hypersensitivity to DNFB 
when ear challenged. The circumstantial link between surface 
density of Langerhans cells and abili ty of skin to permit sensi-
tization to DNFB was strengthened by a time course experi-
ment in which UVL-treated skin was allowed to recover; at 
periodic intervals dur ing the recovery period, UVL-treated skin 
was painted with DNFB in order to determine whether sensi-
tization could be achieved. As can be seen by the results 
presented in Fig 1, there was a parallel association between the 
Sensitization to DNFB: Role of Langerhans cell density 
Skin pain ti ng s ite 
Langerhans cell 
density 
(cells/mm' ) 
Ear swelling 
(x {~~p~:"s'kM) 
Abdominal body wall 770 ± 120 52 ± 2.1 
Dorsal body waH 760 ± 150 50 ± 1.9 
UVL-treated abdominal body wall 50 ± 30 15 ± 0.6 
Tail llO ± 15 16 ± 0.7 
None (Negative control) 10 ± 0.6 
Mice received 2 applications of 25 ,.,1 0.5% DNFB on days 0 and 1. 
Ears were challenged with 20 1-11 of 0.2% DNFB on day 5. Swelling 
measured on day 6 and 7. 
Long er hans 
ce ll density 
(ce ll /mm 2) 
770 
50 
490 
790 
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Re covery of Contact Sensitivity 
Induction Following UVL Skin Irradiation 
Day 
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FIG 1. Panels of mice were UVL treated for 4 days. Skin was assay.ed 
for Langerhans cell density on days -4, 0, 6 and 15. Panels of m1ce 
were painted with 0.5% DNFB through UVL-treated skm on day 0, 6 
or 15. Each panel was ear challenged 5 days after completion of skin 
sensitizing regimen. Bars represent mean ear swelling for groups of 5 
mice ± 1 SEM. 
quantitative return of Langerhans cell density toward normal 
and increasing capacity of that skin to permit DNFB sensiti-
zation. By 15 days after completion of UVL treatments, Lan-
gerhans cell density and morphology was normal, and this 
recovered skin permitted the development of normal sensitiza-
tion to DNFB. Thus, skin depleted of Langerhans cells by UVL 
treatment no longer provides an appropriate medium to pro-
mote sensitization to locally painted DNFB. 
Does Murine Tail Skin Permit Sensitization to DNFB? 
The average Langerhans cell surface density in tail skin is 
considerably less than that of body wall skin; moreover, there 
is a maldistribution of Langerhans cells within tail epidermis: 
they are located at the periphery of tail skin scales, but are not 
present within the scale epidermis itself [18]. 
Panels of mice were painted on body wall skin or tail skin 
twice at 24-hr intervals with 0.5% DNFB in carrier. Five days 
later each panel was challenged on ear skin with 0.2% DNFB. 
The results are presented in the Table. Tail skin proved to be 
an inadequate surface through which to induce DNFB contact 
hypersensitivity. The amount of ear swelling that developed in 
tail skin-painted mice was only 32% that which developed in 
animals painted with DNFB on body wall skin, an amount not 
appreciably greater than the swelling that developed in negative 
control ears (20%). T ail skin shares with UVL-treated body 
wall skin the common property of low density of Langerhans 
cells; when DNFB is painted on either, sensitization fails to 
take place. 
Does exposure to DNFB through Langerhans Cell-Depleted 
Skin Influence Subsequent Sensitization Through Normal 
Skin? 
As mentioned in the Introduction, presentation of haptens by 
extracutaneous routes generally fails to immunize, resulting in 
specific unresponsiveness instead. To test whether skin de-
pleted and/or deficient in Langerhans cells might similarly 
compromise host immune responsiveness, panels of mice were 
first exposed to DNFB by painting tail skin or UVL-treated 
body wall skin by the conventional immunizing regimen. Four-
teen days later each group of mice was subjected again to the 
immunizing regimen, except that this time the painting was 
done on normal body wall skin. The ears of these animals as 
well as appropriate positive and negative controls were chal-
lenged 5 days later with 0.2.% DNFB. The results are presented 
in Fig 2. Exposure to DNFB through Langerhans cell-poor skin 
May 1980 
Langerhans Cell Density of DNFB-Treated Skin Determines 
Subsequent Immune Responsiveness 
First Skin 
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(Day 0) 
None 
DNFB on 
abdominal 
body wall skin 
DNFB on 
toil skin 
DNFB on 
UVL- I rea led 
body wall skin 
Second Skin 
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(Dey 14) 
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body wall skin 
DNFB on dorsal 
body wall skin 
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body wall s~in 
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I 
I 
0 
t 
10 
.~ 
~ 
20 30 40 
Eor Swelling Response 
x 10-4 inches ± SEM 
50 
+ 
60 
FIG 2. Panels of mice were first painted with 0.5% DNFB through 
normal abdominal wall skin, tail skin or UVL-treated skin. 14 days 
later, each panel (plus the positive control) was painted on dorsal body 
wall skin with 0.5% DNFB. Ear challenge was carried out 5 days later. 
Bars represent mean ear swelling for groups of 5 mice ± 1 SEM. 
in each instance resulted in the development of profound un-
responsiveness. Compared to negative controls, the % unre-
sponsiveness achieved was 87.5% and 80% fo! tail skin and 
UVL-treated skin, respectively. In other expenments, the un-
responsiveness was found to be highly specific in that DNFB-
unresponsive animals were able to react vigorously to oxazalone 
[19]. . . . " b lu h ld" Thus while it is true that skm contammg su -t ·es o 
numbe;s of Langerhans cells fails to support sensitization to 
haptenic molecules, the immune system of animals so treated 
is not unperturbed. Instead, animals exposed to DNFB through 
skin deficient in Langerhans cells become profoundly unrespon-
sive, as though they had received their initial exposure to the 
contactant by an extracutaneous route. We conclude that Lan-
gerhans cells provide skin with the unique and special attribute 
of both permitting and promoting the development of contact 
hypersensitivity. 
DISCUSSION 
The study of contact hypersensitivity is important from at 
least 2 standpoints. For the ftrst-and especially since the 
system has been adapted in the last several years to permit its 
investigation among inbred strains of mice-contact hypersen-
sitivity is an extraordinarily useful model to study the process 
by which T lymphocytes perceive antigen and are activated to 
a state of specific immunity. For the second, experimental 
contact hypersensitivity represents a reasonably faithful model 
of human disorders attributable to cell-mediated immunity 
dil·ected at antigens that come in contact with skin. But contact 
hypersensitivity may prove to be a model system with more far 
reaching biologic implications. The derivatization of "self" de-
terminants by highly reactive simple chemicals (haptens) is 
similar in immunologic terms to the modification of cell surfaces 
achieved by the expression of virus-specific antigens. These 
antigens are perceived by T lymphocytes in the context of 
"self" determinants encoded by the major histocompatibility 
complex [20]. And finally , the analogy may be extended further 
to the neoantigens expressed by malignant cells which may also 
induce T-cell mediated immunity in the context of MHC-re-
lated gene products. Assigning a pivotal role to epidermal 
Langerhans cells in the induction and perhaps elicitation of 
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contact (delayed) hypersensitivity is therefore of both theoret-
ical and practical importance. 
Langer hans cells are a dynamic cell population. We are only 
beginning to probe experimentally the ways in which ~he num-
bers and physiologic functions of these cells can be deliberately 
or unwittingly perturbed. Exposure to actinic radiation may 
prove to be a crude method of altering the function of these 
important cells. And altering their function and numbers seems 
to have a profound effect on critical immune reactions. When 
Langerhans cells are present in skin in normal numbers and 
with normal function, they appear to play a sentinel role, 
equipping the cutaneous surface with an elaborate network of 
interlocking dendritic processes, prepared to capture foreign 
materials and render them strongly immunogenic. However, 
when Langerhans cells are absent from the skin or are signifi-
cantly altered in physiologic properties, the network is breached 
and a surprisingly unorthodox face of the immune response is 
unmasked: exposure to foreign agents not only fails to sensitize, 
but evokes profound and specific immunologic unresponsive-
ness. If the ultimate physiologic role for Langerhans cells turns 
out to be that of converting potentially tolerogenic signals 
delivered to the skin into immunogenic ones, then skin devoid 
of these cells and their function may be vulnerable in several 
important ways. ~ 
It has already been reported that La.ngerhans cells form the 
major repository for certain pathogenic viruses that penetrate 
the cornified layer of epidermis [21]. Cutaneous surfaces defi-
cient in Langerhans cells might be particularly susceptible to 
virus onslaught and unable to contain cell to cell spread of the 
agent. We have previously shown that corneal epidermis is 
utterly devoid of Langerhans cells [17] and consequently does 
not. express cell surface ,determinants of the I region of H ,2 [22]. 
Perhaps the devastating and unrelenting infections of the cor-
nea caused by herpes simplex virus infection owe then· perni-
cious cow·se to the absence ofLangerhans cells from that tissue. 
For purposes of discussion one can assume that malignant 
degeneration of keratinocytes and/or melanocytes in the skin 
is a capriciously random event. If_the p__b.enomenon of immu-
nologic surveillance_[23_].is_a__physiolo ic mechanism b which 
the immune system rids t~body of neoplastic cells then the 
stroitg cyrucal association [24-26] between_ rolong!ld exposure 
to actinic radiation and markedly increased incidence -of skin 
cancer may also be linked tlu·ough Langerhans cells. It IS 
attractive to suppose that repeatea exposuretOUVL produces 
a chronic deficiency of epidermalLa.ngerhans_cells._When tbe 
inevitable neopastic 9~ll .or cluster of cells develops within 
epidermis, there _is no sentinel to accept, process and present 
"neoantigens" to the central immunologic machinery as im-
munogens. Instead, the tumor specific antigens, in the absence 
of ~_angerhans cells Uust as PNFB on_ U'{L-treated skill), are 
able to deliver a tolerogenic signal, and thus procure an unmo-
lested ~enure for their illicit progency. 
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DISCUSSION 
GREEN: What happens to the efferent phase of contact reaction if 
you irradiate eaTs with UV light and then try to elicit a reaction in the 
eaTs? 
STREILEIN: I wish I could tell you the answer to that. It is not that 
we haven't tried to do that experiment. It is not possible to deliver UV 
light to ear skin in the same exquisitely uniform way you can to 
abdominal skin. There is one report in the literature in which someone 
claims to have inhibited the expression of contact hypersensitivity in 
guinea pigs with UV light. 
CLARK: Can you elicit a reaction when you paint DNFB on the tails 
of sensitized mice? 
STREILEIN: We have not looked. 
CLARK: Can you tolerize a sensitized mouse by painting DNFB on 
its tail? 
STREILEIN: We've thought about doing that. It is somewhere on the 
list of priorities but not high enough. There is a bias, you know, that it 
is very hard to break through an established sensitized state. 
CLARK: The reason for asking the question is probably obvious and 
that is-are you on the brink of showing us a way in which to tolerize 
people with rhus allergies? 
STREILEIN: You mean people who are already sensitized? l do not 
think we are on the brink of that by any means. 
CLAMAN : It is extraordinarily difficult to desensitize even when you 
have in yom hands powerful to lerogens. The hope of desensitizing rhus 
sensit ive patients is still over the horizon. 
KATZ: Do you get any histological or gross morphologic changes with 
irradiation? 
BERGSTRESSER: We have not looked carefully histologically, al-
though acanthosis without necrosis is the most prominent change. 
Grossly, we get some scale and when we quadrupled the dose we 
produced ulceration after 4 days. After the full series of exposures we 
are near toxicity. 
TIGALAAR: You showed us that the painting of ATP-ase depleted 
skin sites is not an immunologically null event and that the antigen is 
viewed as a tolerogenic stimulus by the animal in terms of its response 
to a second application of allergen. But is the poor response by such an 
animal also diminished when compared to animals skin painted both 
times on normal skin? I do not t hink you showed us that particular 
relevant control group. 
STHEILEIN: One of the controls we did, of course, was simply to paint 
animals on Day 1 and 2 and then on Day 14 and 15 and those animals 
respond well after the 14, 15 painting so there's nothing specia l about 
waiting that 2-week interval. 
EDELSON: Since ultraviolet B, in significant amounts, increases ker-
atinocyte disorganization and percutaneous absorption, yom results 
need to be interpreted in the context of UVB-induced keratinocyte 
damage. Increased percutaneous absorption speaks in favor of a probe 
for an intra-epidermal cell in induction of sensitivi ty to the hapten. 
Could you comment on the potential relevance of these factors? 
STHEILEIN: We are aware that we ru·e changing the barrier by UV 
light t reatment. We are also aware that the barrier is probably different 
in tail scales. And, really, we have no better than circumstantial 
evidenc.e to link Langerhans cell numbers to the failure to sensitize and 
to the unresponsiveness. I am not making any claims beyond that. 
LEVIS: You have shown that you can block a primary sensitization 
to DNFB. What about a rechallenge? 
STREILEIN: Well, we have not achieved Langerhans cell depletion 
with UV light sufficient to make us suspect that it would be worth 
doing the experiment yet. 
